- Home
- SPT vs MDXG Comparison
SPT vs MDXG Comparison
Compare SPT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPT | MDXG |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.6M | 530.2M |
| IPO Year | 2019 | 2007 |
Fundamental Metrics
Financial Performance| Metric | SPT | MDXG |
|---|---|---|
| Price | $8.15 | $3.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $11.75 | $9.00 |
| AVG Volume (30 Days) | ★ 1.5M | 1.4M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.11 | 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $457,547,000.00 | $418,630,000.00 |
| Revenue This Year | $8.86 | N/A |
| Revenue Next Year | $8.04 | $13.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 12.72 | ★ 19.99 |
| 52 Week Low | $4.92 | $3.03 |
| 52 Week High | $22.59 | $7.99 |
Technical Indicators
Market Signals| Indicator | SPT | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 71.63 | 48.42 |
| Support Level | $5.94 | $3.45 |
| Resistance Level | $11.50 | $3.80 |
| Average True Range (ATR) | 0.36 | 0.13 |
| MACD | 0.12 | 0.02 |
| Stochastic Oscillator | 97.89 | 47.14 |
Price Performance
Historical ComparisonAbout SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.